Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
The Journal of Biological Chemistry
|
August 10, 2006
Cloning and characterization of the annexin II receptor on human marrow stromal cells
Ganwei Lu, Hidefumi Maeda, Sakamuri V Reddy, et al.
Molecular Cancer Research : MCR
|
January 26, 2017
EZH2 or HDAC1 Inhibition Reverses Multiple Myeloma-Induced Epigenetic Suppression of Osteoblast Differentiation
Juraj Adamik, Shunqian Jin, Quanhong Sun, et al.
Frontiers in Endocrinology
|
July 17, 2018
XRK3F2 Inhibition of p62-ZZ Domain Signaling Rescues Myeloma-Induced GFI1-Driven Epigenetic Repression of the <i>Runx2</i> Gene in Pre-osteoblasts to Overcome Differentiation Suppression
Juraj Adamik, Rebecca Silbermann, Silvia Marino, et al.
Blood
|
November 6, 2009
Osteoclasts are important for bone angiogenesis
Frank C Cackowski, Judith L Anderson, Kenneth D Patrene, et al.
Cancers
|
February 15, 2022
GFI1-Dependent Repression of <i>SGPP1</i> Increases Multiple Myeloma Cell Survival
Daniela N Petrusca, Patrick L Mulcrone, David A Macar, et al.
The Journal of Biological Chemistry
|
September 6, 2013
Critical role of AKT protein in myeloma-induced osteoclast formation and osteolysis
Huiling Cao, Ke Zhu, Lugui Qiu, et al.
Haematologica
|
November 20, 2023
Pharmacologic targeting of the p62 ZZ domain enhances both anti-tumor and bone-anabolic effects of bortezomib in multiple myeloma
Silvia Marino, Daniela N Petrusca, Ryan T Bishop, et al.
Journal of Hematology & Oncology
|
October 6, 2018
Growth factor independence 1 expression in myeloma cells enhances their growth, survival, and osteoclastogenesis
Daniela N Petrusca, Denise Toscani, Feng-Ming Wang, et al.
Blood
|
November 2, 2011
Gfi1 expressed in bone marrow stromal cells is a novel osteoblast suppressor in patients with multiple myeloma bone disease
Sonia D'Souza, Davide del Prete, Shunqian Jin, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
The Journal of Biological Chemistry
|
August 10, 2006
Cloning and characterization of the annexin II receptor on human marrow stromal cells
Ganwei Lu, Hidefumi Maeda, Sakamuri V Reddy, et al.
Molecular Cancer Research : MCR
|
January 26, 2017
EZH2 or HDAC1 Inhibition Reverses Multiple Myeloma-Induced Epigenetic Suppression of Osteoblast Differentiation
Juraj Adamik, Shunqian Jin, Quanhong Sun, et al.
Frontiers in Endocrinology
|
July 17, 2018
XRK3F2 Inhibition of p62-ZZ Domain Signaling Rescues Myeloma-Induced GFI1-Driven Epigenetic Repression of the <i>Runx2</i> Gene in Pre-osteoblasts to Overcome Differentiation Suppression
Juraj Adamik, Rebecca Silbermann, Silvia Marino, et al.
Blood
|
November 6, 2009
Osteoclasts are important for bone angiogenesis
Frank C Cackowski, Judith L Anderson, Kenneth D Patrene, et al.
Cancers
|
February 15, 2022
GFI1-Dependent Repression of <i>SGPP1</i> Increases Multiple Myeloma Cell Survival
Daniela N Petrusca, Patrick L Mulcrone, David A Macar, et al.
The Journal of Biological Chemistry
|
September 6, 2013
Critical role of AKT protein in myeloma-induced osteoclast formation and osteolysis
Huiling Cao, Ke Zhu, Lugui Qiu, et al.
Haematologica
|
November 20, 2023
Pharmacologic targeting of the p62 ZZ domain enhances both anti-tumor and bone-anabolic effects of bortezomib in multiple myeloma
Silvia Marino, Daniela N Petrusca, Ryan T Bishop, et al.
Journal of Hematology & Oncology
|
October 6, 2018
Growth factor independence 1 expression in myeloma cells enhances their growth, survival, and osteoclastogenesis
Daniela N Petrusca, Denise Toscani, Feng-Ming Wang, et al.
Blood
|
November 2, 2011
Gfi1 expressed in bone marrow stromal cells is a novel osteoblast suppressor in patients with multiple myeloma bone disease
Sonia D'Souza, Davide del Prete, Shunqian Jin, et al.
Page
of 1